IHH Healthcare (5225) Financial Ratio Screen
Follow screening changes
Email alerts are not currently available. Bookmark this page and check the financial period and retrieval date when reviewing a result.
MSCI new-inclusion financial-ratio snapshot
5225 financial screening at a glance
Calculation date: 2026-10-15. Financial period used: December 2025. The ratios are automated proxies inspired by published methodologies; they are not official index determinations.
Independent method comparison
What the available screens say
How MSCI, FTSE and S&P-style screens differThe request button opens your email application with a pre-filled message. HalalStockGuide receives no address or request unless you choose to send it.
Business activity evidence
Activity assessment in progress
The supplied classification (Medical Care Facilities) is only a starting point. Revenue evidence is being assessed before any complete screening conclusion.
Revenue segments: Not yet checked against an SEC annual filing.
Profile description reviewed: IHH Healthcare Berhad, an investment holding company, provides healthcare services in Singapore, Malaysia, India, Greater China, Japan, Türkiye and Europe, and internationally. The company offers primary care services, such as outpatient treatment, check-ups, vaccinations, preventive care, and patient education services; secondary and tertiary care services, including medical emergencies and acute treatment, diagnostics and lab services; quaternary services comprising specialist consultative care, advanced treatment, complex surgery, and inpatient care services; and quaternary care services, such as organ transplants, neurosurgery, cardiac surgery, and reconstructive plastic surgery; and complementary ancillary services. It also engages in the provision of catering, laundry, and cleaning services for hospitals, as well as services of preparation and serving food; supervise and manage the construction of healthcare facilities; conduct research, develop, and market healthcare information systems, web-based applications, and other technology solutions; e-consulting and marketplace activities relating to all health-related products; import and wholesale of drug and medical materials; and operates pharmacy. In addition, the company provides facility management and building maintenance; clinical research; rehabilitation; administrative support; comprehensive professional oncological services, such as diagnostic, radiotherapy, and chemotherapy treatment; courses in nursing and allied health; agent and administrator for managed care and related services; and computer software designing development, customization, integration, implementation, maintenance, and related services. Further, it is involved in development, construction, and leasing of medical facility buildings; retail sale of pharmaceutical, medical, and orthopaedic goods; and property development. IHH Healthcare Berhad was incorporated in 2010 and is based in Kuala Lumpur, Malaysia.
Sources to verify: Secondary company profile and classification · Issuer website
A sector label or company description can flag a risk but cannot establish a compliant-revenue percentage. Only sourced segment disclosures may support that calculation.
Published-ratio reproductions (not certifications)
The table shows implemented MSCI and FTSE/Yasaar-style asset-based models plus a provisional S&P-style debt and cash reconstruction where a complete 36-month denominator exists. These are independent calculations, not official index results or Shariah determinations. See formulas, sources and limitations.
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| MSCI | 27.0% / 30% | 4.0% / 30% | 7.7% / 30% | 0.69% / 5% | FINANCIAL SCREEN PASSED* |
| FTSE | 27.0% / 33% | 4.0% / 33% | 7.7% / 50% | 0.69% / 5% | FINANCIAL SCREEN PASSED* |
Financial Highlights
Profitability
| Gross Margin | 33.2% | |
| Operating Margin | 15.2% | |
| Net Margin | 8.4% | |
| Return on Equity (ROE) | 8.1% | |
| Return on Assets (ROA) | 4.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | MYR 5.6B |
| Free Cash Flow | MYR 1.9B |
| Total Debt | MYR 15.5B |
| Debt-to-Equity | 43.2 |
| Current Ratio | 0.6 |
| Total Assets | MYR 57.6B |
Price & Trading
| Last Close | MYR 7.88 |
| 50-Day MA | MYR 8.06 |
| 200-Day MA | MYR 8.58 |
| Avg Volume | 5.1M |
| Beta | 0.2 |
|
52-Week Range
MYR 7.54
| |
Financial data provenance and verification
The displayed fields were imported from yfinance on 2026-10-09 for the financial period December 2025. This is a secondary data feed and can differ from amended or newly filed statements.
- Issuer website — use its investor-relations filings to verify the figures.
- Field mapping, formulas and limitations.
Verification rule: check debt, cash, receivables, revenue and interest income against the latest primary filing before relying on an automated ratio.
About IHH Healthcare (5225)
IHH Healthcare Berhad, an investment holding company, provides healthcare services in Singapore, Malaysia, India, Greater China, Japan, Türkiye and Europe, and internationally. The company offers primary care services, such as outpatient treatment, check-ups, vaccinations, preventive care, and patient education services; secondary and tertiary care services, including medical emergencies and acute treatment, diagnostics and lab services; quaternary services comprising specialist consultative care, advanced treatment, complex surgery, and inpatient care services; and quaternary care services, such as organ transplants, neurosurgery, cardiac surgery, and reconstructive plastic surgery; and complementary ancillary services. It also engages in the provision of catering, laundry, and cleaning services for hospitals, as well as services of preparation and serving food; supervise and manage the construction of healthcare facilities; conduct research, develop, and market healthcare information systems, web-based applications, and other technology solutions; e-consulting and marketplace activities relating to all health-related products; import and wholesale of drug and medical materials; and operates pharmacy. In addition, the company provides facility management and building maintenance; clinical research; rehabilitation; administrative support; comprehensive professional oncological services, such as diagnostic, radiotherapy, and chemotherapy treatment; courses in nursing and allied health; agent and administrator for managed care and related services; and computer software designing development, customization, integration, implementation, maintenance, and related services. Further, it is involved in development, construction, and leasing of medical facility buildings; retail sale of pharmaceutical, medical, and orthopaedic goods; and property development. IHH Healthcare Berhad was incorporated in 2010 and is based in Kuala Lumpur, Malaysia.
Popular halal stock checks
Explore other frequently viewed automated stock screens and compare the available financial ratios.
Frequently Asked Questions
Is IHH Healthcare (5225) halal to invest in?
The current automated result is Financial screen passed; activity assessment pending. It uses available public financial fields and simplified methodology proxies. It is not a fatwa or an official determination by AAOIFI, DJIM, MSCI, S&P, or FTSE.
What is IHH Healthcare's debt ratio?
IHH Healthcare's debt ratio is 27.0% in the MSCI new-inclusion reproduction: total debt divided by total assets, against a 30% threshold. See the methodology page for the official source and limitations.
What are IHH Healthcare's key financial metrics?
IHH Healthcare has a market capitalization of MYR 69541M in its listing currency, trailing P/E ratio of 31.5, and revenue of MYR 25.7B. The company maintains a gross margin of 33.2% and a net margin of 8.4%. Return on equity stands at 8.1%.
How often is the screening data updated?
Calculation date: 2026-10-15. Financial period: December 2025. These dates are shown separately because regenerating this page does not refresh the underlying data.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.